Tag: AV access

IN.PACT AV access results show “unrivalled patency” and highly reduced reintervention...

Jos van den Berg (Lugano, Switzerland) speaks to Andrew Holden (Auckland, New Zealand) to distil the headline findings from the first-ever results of the...
VasQ

First patients enrolled in US pivotal trial of the VasQ device

The first patients have been enrolled in the US FDA pivotal study of VasQ (Laminate Medical Technologies), an implanted blood vessel external support device...

TVA Medical receives CE mark for everlinQ 4 endovascular AVF system

TVA Medical’s everlinQ 4 endovascular arteriovenous fistula (AVF) system has received CE mark in the European Union. The technology uses a 4F catheter system...

Bard gets FDA premarket approval of the Lutonix 035 DCB for...

Bard’s Lutonix 035 drug-coated balloon PTA catheter (DCB) has been granted premarket approval (PMA) by the US Food and Drug Administration (FDA) for a...

Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous...

Scott Trerotola presented the first release of eight-month data from the Lutonix AV trial at the Leipzig Interventional Course (LINC; 24–27 January, Leipzig, Germany)...

Mechanical approaches to improving AV fistula outcomes

Although arteriovenous (AV) fistulae are considered the gold standard for vascular access for haemodialysis and have a low rate of complications and improved longevity...

Promising early results for Lutonix US IDE trial in obstructed AV...

The first US randomised controlled trial for drug-coated balloon use for arteriovenous fistula obstructions for 50 years, the Lutonix (Bard) IDE trial was a...

Merit Medical launches Super HeRO and HeRO Ally products

Merit Medical Systems has announced the launch of the proprietary Super HeRO and HeRO Ally products, additions to Merit’s expanding portfolio of dialysis access...

NEAT trial shows six times fewer post-creation interventions with endovascular than...

NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...

New developments in dialysis grafts

With the rising incidence of haemodialysis worldwide, there is an ever-increasing need for creative, durable means of access. The National Kidney Foundation and Centers...

Gore Viabahn endoprosthesis celebrates 20 years since introduction

Gore is celebrating the 20th anniversary of the introduction of the Viabahn endoprosthesis; its stent graft for the treatment of complex peripheral vascular disease....